Relatlimab With Nivolumab and 5-Azacytidine for the Treatment of AML
Clinical trial NCT04913922 · UNKNOWN
Trial details
- NCT number
- NCT04913922
- Sponsor
- Ludwig-Maximilians - University of Munich
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-05
- Primary completion
- 2025-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.